Condensed Consolidated Financial Statements Detail (Tables)

3 Months Ended

Mar. 31, 2021

Condensed Consolidated Financial Statements Detail [Abstract]

Accrued and Other Liabilities

Accrued and other liabilities consisted of the following (in thousands):

	March 31,		December 31,
	2021		2020
Accrued legal and accounting fees	$	949	$	351
Accrued incentive compensation		231		71
Accrued payroll and other benefits		111		136
Other		50		40
Interest payable		35		44
Total	$	1,376	$	642

Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net (Loss) per Share Available to Common Stockholders

The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):

	Three Months Ended March 31,
	2021		2020
Numerator
Net loss	$	(7,373)	$	(4,758)
Less: Series A accumulated dividends		(530)		—
Net loss available to common stockholders, basic and diluted	$	(7,903)	$	(4,758)
Denominator
Weighted average shares used in computing basic and diluted net loss per share available to common stockholders		11,240		9,761
Basic and diluted net loss per share of common stock	$	(0.70)	$	(0.49)

Outstanding Securities Considered Anti-Dilutive

The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders (in thousands):

	Three Months Ended March 31,
	2021	2020
Convertible preferred stock	5,003	6,256
Common stock options	277	532
Warrants for common stock	5	15
Total	5,285	6,803